Etoposide
- Product NDC
- 68001-683
- 11-digit product format
- 680010683
- Labeler code
- 68001
- Product ID
- 68001-683_52475e80-bf46-f251-e063-6294a90a0e10
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Etoposide
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- BluePoint Laboratories
- Application
- ANDA074529
- Marketing category
- ANDA
- Marketing start
- 2025-12-01
- Substance
- ETOPOSIDE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Etoposide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ETOPOSIDE | 20 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6PLQ3CP4P3 |
| Rxcui | 310248 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68001-683-27 | Etoposide | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION, CONCENTRATE | 50 | | 2 |
| 68001-683-27 | Etoposide | 1 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 1 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 68001-683-27 | 68001068327 | 1 VIAL, MULTI-DOSE in 1 CARTON (68001-683-27) / 50 mL in 1 VIAL, MULTI-DOSE | 2025-12-01 | No | No | Historical |